83 studies found for:    Adenovirus cancer gene therapy
Show Display Options
Rank Status Study
1 Terminated Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Intervention: Genetic: Ad5-yCD/mutTKSR39rep-ADP
2 Withdrawn Gene Therapy for Prostate Cancer That Returns After Radiation Therapy
Conditions: Prostatic Neoplasms;   Neoplasm Recurrence, Local
Intervention: Genetic: Ad.hIL-12
3 Unknown  Randomized Trial of Suicide Gene Therapy and Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: Ad5-yCD/mutTKSR39rep-ADP;   Radiation: IMRT
4 Completed Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: Ad5CMV-p53 gene;   Procedure: conventional surgery
5 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
6 Active, not recruiting Gene Therapy for Pleural Malignancies
Conditions: Pleural Mesothelioma;   Metastatic Pleural Effusions
Interventions: Biological: Adenoviral-mediated Interferon-beta;   Biological: SCH 721015
7 Unknown  Gene Therapy in Treating Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: adenovirus-mediated human interleukin-12;   Other: enzyme-linked immunosorbent assay;   Other: fluorescence activated cell sorting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
8 Completed Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: recombinant adenovirus-p53 SCH-58500;   Procedure: conventional surgery
9 Completed Gene Therapy in Treating Patients With Primary Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: gene therapy;   Drug: chemotherapy;   Drug: ganciclovir;   Procedure: conventional surgery
10 Unknown  Trial of E10A in Head and Neck Cancer
Conditions: Head and Neck Squamous Carcinoma;   Nasopharyngeal Carcinoma
Interventions: Drug: E10A;   Drug: Cisplatin;   Drug: Paclitaxel
11 Terminated Gene Therapy in Treating Patients With Cancer of The Liver
Condition: Liver Cancer
Intervention: Biological: Ad5CMV-p53 gene
12 Completed Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Genetic: IL-12 gene
13 Unknown  Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor
Condition: Advanced Solid Tumor
Interventions: Drug: Antangiogenesis;   Genetic: endostatin gene
14 Completed Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: Ad5CMV-p53 gene;   Radiation: radiation therapy
15 Completed Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: adenovirus RSV-TK;   Drug: ganciclovir
16 Completed Gene Therapy in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Surgically Removed
Condition: Lung Cancer
Intervention: Biological: Ad5CMV-p53 gene
17 Recruiting Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Conditions: Transitional Cell Carcinoma;   Bladder Cancer;   Carcinoma in Situ;   Carcinoma in Situ Concurrent With Papillary Tumors
Interventions: Biological: CG0070 adenovirus vector;   Other: Control Arm: Quadruple Choice
18 Completed Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Conditions: Head and Neck Cancer;   Advanced Solid Tumors
Intervention: Genetic: Ad/PNP and fludarabine monophosphate
19 Completed TK-based Suicide Gene Therapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: TK99UN
20 Terminated Wild Type p53 Adenovirus for Oral Premalignancies
Condition: Mouth Cancer
Intervention: Genetic: INGN 201

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years